0001179110-18-014224.txt : 20181221 0001179110-18-014224.hdr.sgml : 20181221 20181221160022 ACCESSION NUMBER: 0001179110-18-014224 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181219 FILED AS OF DATE: 20181221 DATE AS OF CHANGE: 20181221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOREVIC JASON N CENTRAL INDEX KEY: 0001208500 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 181249482 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 edgar.xml FORM 4 - X0306 4 2018-12-19 0 0001477449 Teladoc Health, Inc. TDOC 0001208500 GOREVIC JASON N C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 1 1 0 0 Chief Executive Officer Common Stock 2018-12-19 4 M 0 30000 1.07 A 536184 D Common Stock 2018-12-19 4 S 0 30000 49.55 D 506184 D Common Stock 2018-12-20 4 M 0 31870 1.07 A 538054 D Common Stock 2018-12-20 4 M 0 22401 1.67 A 560455 D Common Stock 2018-12-20 4 M 0 9988 1.67 A 570443 D Common Stock 2018-12-20 4 M 0 33276 6.01 A 603719 D Employee Stock Option (right to buy) 1.07 2018-12-19 4 M 0 30000 0.00 D 2022-04-16 Common Stock 30000 90026 D Employee Stock Option (right to buy) 1.07 2018-12-20 4 M 0 31870 0.00 D 2022-04-16 Common Stock 31870 58156 D Employee Stock Option (right to buy) 1.67 2018-12-20 4 M 0 22401 0.00 D 2023-12-11 Common Stock 22401 67205 D Employee Stock Option (right to buy) 1.67 2018-12-20 4 M 0 9988 0.00 D 2023-12-11 Common Stock 9988 79618 D Employee Stock Option (right to buy) 6.01 2018-12-20 4 M 0 33276 0.00 D 2024-12-22 Common Stock 33276 122243 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 8, 2018. Represents the weighted average price of transactions ranging from $49.26 to $50.24. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. The option vested as to 25% of the shares on January 1, 2015 The remainder of the shares vested or will vest in 30 equal monthly installments thereafter. The option vested as to 25% of the shares on January 1, 2016. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. The option vested as to 25% of the shares on December 22, 2015. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter. /s/ Adam C. Vandervoort, attorney-in-fact 2018-12-21